CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment-Reference-Cited by-同舟云学术

CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment

Published:2016-08-25 Issue:8 Volume:11 Page:e0161618
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hotta Ryuichi,Ohira Masahiro,Matsuura Toshiharu,Muraoka Izumi,Tryphonopoulos Panagiotis,Fan Ji,Tekin Akin,Selvaggi Gennaro,Levi David,Ruiz Phillip,Ricordi Camillo,Vianna Rodrigo,Ohdan Hideki,Waldmann Herman,Tzakis Andreas G.,Nishida Seigo

Funder

Florida Department of Health and the Bankhead-Coley Cancer Research Program

JSPS Grant-in-Aid for Young Scientists (B)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference19 articles.

1. The CAMPATH-1 antigen (CDw52);G Hale;Tissue Antigens,1990

2. Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation;J Sageshima;Transpl Immunol,2011

3. Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection;K Upadhyay;Pediatr Transplant,2012

4. Biology of natural killer cells;G Trinchieri;Adv Immunol,1989

5. Natural killer cell receptor signaling;LL Lanier;Curr Opin Immunol,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity;Journal of Clinical Immunology;2024-05-22

2. Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study;Blood Advances;2023-08-11

3. Protective and pathogenic functions of innate lymphoid cells in transplantation;Clinical and Experimental Immunology;2023-04-29

4. Comment to: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia;Cellular & Molecular Immunology;2021-04-23

5. Immunosuppression in Liver Transplantation: State of the Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31